| Date | Time | Source | Headline | Symbol | Company |
| 08/27/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD | NASDAQ:CLSD | Clearside Biomedical Inc |
| 08/12/2024 | 4:30PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:CLSD | Clearside Biomedical Inc |
| 08/12/2024 | 4:15PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CLSD | Clearside Biomedical Inc |
| 08/12/2024 | 4:05PM | GlobeNewswire Inc. | Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update | NASDAQ:CLSD | Clearside Biomedical Inc |
| 08/08/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference | NASDAQ:CLSD | Clearside Biomedical Inc |
| 08/01/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 | NASDAQ:CLSD | Clearside Biomedical Inc |
| 07/29/2024 | 4:05PM | GlobeNewswire Inc. | Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China | NASDAQ:CLSD | Clearside Biomedical Inc |
| 07/24/2024 | 7:55AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CLSD | Clearside Biomedical Inc |
| 07/22/2024 | 12:00PM | GlobeNewswire Inc. | Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET | NASDAQ:CLSD | Clearside Biomedical Inc |
| 07/11/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board | NASDAQ:CLSD | Clearside Biomedical Inc |
| 06/27/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery | NASDAQ:CLSD | Clearside Biomedical Inc |
| 06/12/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting | NASDAQ:CLSD | Clearside Biomedical Inc |
| 05/21/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® | NASDAQ:CLSD | Clearside Biomedical Inc |
| 05/10/2024 | 4:31PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:CLSD | Clearside Biomedical Inc |
| 05/09/2024 | 4:10PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CLSD | Clearside Biomedical Inc |
| 05/09/2024 | 4:05PM | GlobeNewswire Inc. | Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update | NASDAQ:CLSD | Clearside Biomedical Inc |
| 05/08/2024 | 4:15PM | GlobeNewswire Inc. | Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference | NASDAQ:CLSD | Clearside Biomedical Inc |
| 04/30/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 | NASDAQ:CLSD | Clearside Biomedical Inc |
| 04/16/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors | NASDAQ:CLSD | Clearside Biomedical Inc |
| 04/02/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference | NASDAQ:CLSD | Clearside Biomedical Inc |
| 03/18/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | NASDAQ:CLSD | Clearside Biomedical Inc |
| 03/12/2024 | 4:05PM | GlobeNewswire Inc. | Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | NASDAQ:CLSD | Clearside Biomedical Inc |
| 02/29/2024 | 7:05AM | GlobeNewswire Inc. | Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024 | NASDAQ:CLSD | Clearside Biomedical Inc |
| 02/08/2024 | 5:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CLSD | Clearside Biomedical Inc |
| 02/08/2024 | 4:52PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:CLSD | Clearside Biomedical Inc |
| 02/07/2024 | 8:00AM | GlobeNewswire Inc. | Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering | NASDAQ:CLSD | Clearside Biomedical Inc |
| 02/01/2024 | 4:01PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CLSD | Clearside Biomedical Inc |
| 01/19/2024 | 6:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CLSD | Clearside Biomedical Inc |
| 01/19/2024 | 3:04PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:CLSD | Clearside Biomedical Inc |
| 12/28/2023 | 4:10PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CLSD | Clearside Biomedical Inc |